4.5 Article

Synthesis, biological evaluation and structure-activity relationship studies of isoflavene based Mannich bases with potent anti-cancer activity

期刊

BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
卷 25, 期 22, 页码 5377-5383

出版社

PERGAMON-ELSEVIER SCIENCE LTD
DOI: 10.1016/j.bmcl.2015.09.027

关键词

Isoflavene; Phenoxodiol; Anti-cancer; Mannich base; Benzoxazine

资金

  1. University of New South Wales
  2. Australian Research Council

向作者/读者索取更多资源

Phenoxodiol, an analogue of the isoflavone natural product daidzein, is a potent anti-cancer agent that has been investigated for the treatment of hormone dependent cancers. This molecular scaffold was reacted with different primary amines and secondary amines under different Mannich conditions to yield either benzoxazine or aminomethyl substituted analogues. These processes enabled the generation of a diverse range of analogues that were required for structure-activity relationship (SAR) studies. The resulting Mannich bases exhibited prominent anti-proliferative effects against SHEP neuroblastoma and MDA-MB-231 breast adenocarcinoma cell lines. Further cytotoxicity studies against MRC-5 normal lung fibroblast cells showed that the isoflavene analogues were selective towards cancer cells. (C) 2015 Elsevier Ltd. All rights reserved.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.5
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

Article Infectious Diseases

Short Tryptamine-Based Peptoids as Potential Therapeutics for Microbial Keratitis: Structure-Function Correlation Studies

Ghayah Bahatheg, Rajesh Kuppusamy, Muhammad Yasir, David StC Black, Mark Willcox, Naresh Kumar

Summary: This study describes the development of short cationic peptoids with activity against Staphylococcus aureus strains from keratitis. The peptoids showed good antimicrobial activity against multiple strains, making them a promising class of antimicrobials.

ANTIBIOTICS-BASEL (2022)

Review Chemistry, Multidisciplinary

Hyaluronic Acid within Self-Assembling Nanoparticles: Endless Possibilities for Targeted Cancer Therapy

Manuela Curcio, Orazio Vittorio, Jessica Lilian Bell, Francesca Iemma, Fiore Pasquale Nicoletta, Giuseppe Cirillo

Summary: This review focuses on the unique application of self-assembling nanoparticles (SANPs) based on hyaluronic acid (HA) in cancer therapy. By combining the targeting activity of HA towards cancer cells with the advantages of self-assembling nanosystems, these SANPs can be used to fabricate delivery devices. The review analyzes the pros and cons of different nanosystems based on HA and discusses the most promising strategies for further research and therapeutic protocol development.

NANOMATERIALS (2022)

Article Oncology

GD2-targeting CAR-T cells enhanced by transgenic IL-15 expression are an effective and clinically feasible therapy for glioblastoma

Tessa Gargett, Lisa M. Ebert, Nga T. H. Truong, Paris M. Kollis, Kristyna Sedivakova, Wenbo Yu, Erica C. F. Yeo, Nicole L. Wittwer, Briony L. Gliddon, Melinda N. Tea, Rebecca Ormsby, Santosh Poonnoose, Jake Nowicki, Orazio Vittorio, David S. Ziegler, Stuart M. Pitson, Michael P. Brown

Summary: Targeting the tumor-associated antigen GD2 using CAR-T-cell therapy has shown promising results in controlling tumor growth in primary glioblastoma. Highly functional GD2-specific CAR-T cells can be produced using an approved clinical manufacturing process. The use of markers identified in the study has further improved tumor control rates.

JOURNAL FOR IMMUNOTHERAPY OF CANCER (2022)

Article Oncology

ONC201 in Combination with Paxalisib for the Treatment of H3K27-Altered Diffuse Midline Glioma

Evangeline R. Jackson, Ryan J. Duchatel, Dilana E. Staudt, Mika L. Persson, Abdul Mannan, Sridevi Yadavilli, Sarah Parackal, Shaye Game, Wai Chin Chong, W. Samantha N. Jayasekara, Marion Le Grand, Padraic S. Kearney, Alicia M. Douglas, Izac J. Findlay, Zacary P. Germon, Holly P. McEwen, Tyrone S. Beitaki, Adjanie Patabendige, David A. Skerrett-Byrne, Brett Nixon, Nathan D. Smith, Bryan Day, Neevika Manoharan, Sumanth Nagabushan, Jordan R. Hansford, Dinisha Govender, Geoff B. McCowage, Ron Firestein, Meegan Howlett, Raelene Endersby, Nicholas G. Gottardo, Frank Alvaro, Sebastian M. Waszak, Martin R. Larsen, Yolanda Colino-Sanguino, Fatima Valdes-Mora, Andria Rakotomalala, Samuel Meignan, Eddy Pasquier, Nicolas Andre, Esther Hulleman, David D. Eisenstat, Nicholas A. Vitanza, Javad Nazarian, Carl Koschmann, Sabine Mueller, Jason E. Cain, Matthew D. Dun

Summary: Diffuse midline gliomas are highly lethal childhood cancers. Palliative radiotherapy is the only established treatment with limited survival benefits. ONC201, a combination of a DRD2 antagonist and ClpP agonist, has shown promising preclinical and emerging clinical efficacy in treating diffuse intrinsic pontine gliomas. Further research is needed to understand the mechanisms of response, the impact of recurring genomic features, and the potential combination therapy with a brain penetrant PI3K/Akt inhibitor, paxalisib.

CANCER RESEARCH (2023)

Article Infectious Diseases

Tuning the Anthranilamide Peptidomimetic Design to Selectively Target Planktonic Bacteria and Biofilm

Rajesh Kuppusamy, Muhammad Yasir, Tsz Tin Yu, Florida Voli, Orazio Vittorio, Michael J. Miller, Peter Lewis, David StC Black, Mark Willcox, Naresh Kumar

Summary: There is an urgent need for new antimicrobial agents to address the global increase in antibiotic resistance. This study focused on producing short amphiphilic antibacterial and antibiofilm agents by modifying the hydrophobic and cationic groups of anthranilamide peptidomimetics. The addition of a lysine cationic group at the tail position significantly enhanced activity against E. coli and reduced cytotoxicity against mammalian cells. These compounds demonstrated notable disruption of preformed biofilms of S. aureus at micromolar concentrations.

ANTIBIOTICS-BASEL (2023)

Article Biochemistry & Molecular Biology

Antimicrobial Peptidomimetics Prevent the Development of Resistance against Gentamicin and Ciprofloxacin in Staphylococcus and Pseudomonas Bacteria

Katrina Browne, Rajesh Kuppusamy, William R. Walsh, David StC Black, Mark D. P. Willcox, Naresh Kumar, Renxun Chen

Summary: Antibiotic resistance is a global challenge, and combination therapies using antibiotics and antimicrobial peptidomimetics can mitigate the development of resistance in bacteria. This strategy demonstrates synergistic activity against both Gram-positive and Gram-negative bacteria and has significant potential in clinical applications.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2023)

Article Crystallography

Short Fluoroalkanes Suppress a Thermally-Induced Phase Transition in a Layered Organic Crystal

Christopher E. Marjo, Anne M. Rich, Mohan M. Bhadbhade, Saroj Bhattacharyya, Songyan Yin, David M. Miskovic, Vina R. Aldilla, Naresh Kumar

Summary: This study investigates a layered crystal system with hydrogen-bonded chloro-s-triazine rings functionalised with alkyl or fluoroalkyl chains. The results show that the crystal undergoes a thermally-induced phase transition when substituted with N-propyl chains, but the phase transition is successfully suppressed when replaced with fluorinated N-propyl chains. The study also suggests that short-chain fluoroalkanes can exert strong control over the assembly and stability of an organic crystal.

CRYSTALS (2023)

Article Medicine, General & Internal

Combination drug screen targeting glioblastoma core vulnerabilities reveals pharmacological synergisms

Jeremy Ariey-Bonnet, Raphael Berges, Marie-Pierre Montero, Baptiste Mouysset, Patricia Piris, Kevin Muller, Guillaume Pinna, Tim W. Failes, Greg M. Arndt, Philippe Morando, Nathalie Baeza-Kallee, Carole Colin, Olivier Chinot, Diane Braguer, Xavier Morelli, Nicolas Andre, Manon Carre, Emeline Tabouret, Dominique Figarella-Branger, Marion Le Grand, Eddy Pasquier

Summary: This study identified targetable vulnerabilities in glioblastoma using high-throughput screening, target deconvolution, and functional genomics. They validated the role of the top gene hit and discovered pharmacological synergisms through drug combination screens. The efficacy of the AURKA/BET inhibitor combination in glioblastoma was confirmed in pre-clinical models.

EBIOMEDICINE (2023)

Article Infectious Diseases

Synthesis of Novel Quinazolinone Analogues for Quorum Sensing Inhibition

Sahil Shandil, Tsz Tin Yu, Shekh Sabir, David StC. Black, Naresh Kumar

Summary: As bacteria develop resistance against antimicrobials, alternative methods to tackle this issue must be developed. In this study, quinazolinone inhibitors were designed using molecular docking to target the pqs system in P. aeruginosa. Compound 6b showed the highest pqs inhibitory activity and no bacterial growth inhibition.

ANTIBIOTICS-BASEL (2023)

Article Infectious Diseases

Antiviral Activity of Anthranilamide Peptidomimetics against Herpes Simplex Virus 1 and a Coronavirus

Umme Laila Urmi, Samuel Attard, Ajay Kumar Vijay, Mark D. P. Willcox, Naresh Kumar, Salequl Islam, Rajesh Kuppusamy

Summary: The development of potent antiviral agents is crucial for combating viral infections worldwide. In this study, the antiviral potential of 17 peptidomimetic compounds was evaluated against MHV-1 and HSV-1. Compounds 11 and 14 showed the most potent inhibitory effects, and they were found to directly influence the viral envelope. These findings suggest that peptidomimetic compounds could offer a new approach for the development of potent antiviral agents.

ANTIBIOTICS-BASEL (2023)

Article Chemistry, Multidisciplinary

Conditional generation of free radicals by selective activation of alkoxyamines: towards more effective and less toxic targeting of brain tumors

Patricia Piris, Duje Buric, Toshihide Yamasaki, Paul Huchede, Mailys Rossi, Melanie Matteudi, Marie-Pierre Montero, Anne Rodallec, Romain Appay, Christine Roux, Sebastien Combes, Eddy Pasquier, Marie Castets, Nicolas Andre, Paul Bremond, Manon Carre

Summary: Brain tumors, particularly glioblastoma and medulloblastoma, are highly lethal and difficult to treat. This study presents a novel approach using alkoxyamines and a bioconjugate called ALK4-MMPp to inhibit the progression of these tumors. The compounds showed promising results in in vitro and in vivo experiments, suggesting their potential as effective anticancer drug candidates. The study also developed innovative models to monitor treatment response and demonstrated the selective targeting of tumor cells without significant damage to normal brain tissue.

CHEMICAL SCIENCE (2023)

Meeting Abstract Oncology

Engineering new cellular models to decipher H3.3K27M mutation role in DIPGs' resistance to therapies

Andria Rakotomalala, Paul Lewandowski, Quentin Bailleul, Clara Savary, Melanie Arcicasa, Christine Bal, Maud Hamadou, Paul Huchede, Audrey Restouin, Remy Castellano, Yves Collette, Audrey Vincent, Pierre-Olivier Angrand, Eric Adriaenssens, Xuefen Le Bourhis, Pierre Leblond, Marie Castets, Eddy Pasquier, Alessandro Furlan, Samuel Meignan

CANCER RESEARCH (2022)

Meeting Abstract Oncology

PHARMACO-PHOSPHO-PROTEO-GENOMICS OF PEDIATRIC HIGH-GRADE GLIOMAS - A PILOT STUDY

Izac Findlay, Dilana Staudt, Padraic Kearney, Holly McEwen, Ryan Duchatel, Evangeline Jackson, Tyrone Beitaki, Nathan Smith, Nicholas Vitanza, Ron Firestein, Jason Cain, Sabine Mueller, Eddy Pasquier, Carl Koschmann, Esther Hulleman, Javad Nazarian, Mitchell Hansen, Frank Alvaro, Melissa Davis, Sebastian Waszak, Matthew Dun

NEURO-ONCOLOGY (2022)

Meeting Abstract Oncology

PRECLINICAL AND CASE STUDY EXAMINATION OF THE COMBINATION OF THE CLPP AGONIST ONC201 WITH THE PI3K/AKT INHIBITOR PAXALISIB FOR THE TREATMENT OF DIFFUSE MIDLINE GLIOMA.

Evangeline Jackson, Ryan Duchatel, Mika Persson, Abdul Mannan, Sridevi Yadavilli, Sarah Parackal, Shaye Game, Wai Chin Chong, Samantha Jayasekara, Marion Le Grand, Padraic Kearney, Alicia Douglas, Izac Findlay, Dilana Staudt, Zacary Germon, David Skerrett-Byrne, Brett Nixon, Nathan Smith, Esther Hulleman, Bryan Day, Geoffrey McCowage, Frank Alvaro, Sebastian Waszak, Martin Larsen, Yolanda Colino-Sanguino, Fatima Valdes-Mora, Andria Rakotomalala, Samuel Meignan, Eddy Pasquier, Nicholas Vitanza, Javad Nazarian, Carl Koschmann, Jason Cain, Sabine Mueller, Matthew Dun

NEURO-ONCOLOGY (2022)

Article Chemistry, Medicinal

Design and synthesis of a library of C2-substituted sulfamidoadenosines to probe bacterial permeability

Shibin Zhao, Julian Maceren, Mia Chung, Samantha Stone, Raphael Geiben, Melissa L. Boby, Bradley S. Sherborne, Derek S. Tan

Summary: Antibiotic resistance is a major threat to public health, with Gram-negative bacteria presenting unique challenges due to their low permeability and efflux pumps. Limited understanding of the chemical rules for overcoming these barriers hinders antibacterial drug discovery. Efforts to address this issue, such as screening compound libraries and using cheminformatic analysis, have led to the design of sulfamidoadenosines with diverse substituents, showing potential utility in accumulation in Escherichia coli.

BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2024)

Article Chemistry, Medicinal

Design of MERS-CoV entry inhibitory short peptides based on helix-stabilizing strategies

Jichun Li, Qing Li, Shuai Xia, Jiahuang Tu, Longbo Zheng, Qian Wang, Shibo Jiang, Chao Wang

Summary: This study successfully developed a short peptide mimetic as a MERS-CoV fusion inhibitor by reproducing the key recognition features of the HR2 helix. The resulting 23-mer lipopeptide showed comparable inhibitory effect to the 36-mer HR2 peptide HR2P-M2. This has important implications for developing short peptide-based antiviral agents to treat MERS-CoV infection.

BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2024)

Article Chemistry, Medicinal

Development of novel β2-adrenergic receptor agonists for the stimulation of glucose uptake - The importance of chirality and ring size of cyclic amines

Krista Jaunsleine, Linda Supe, Jana Spura, Sten van Beek, Anna Sandstrom, Jessica Olsen, Carina Halleskog, Tore Bengtsson, Ilga Mutule, Benjamin Pelcman

Summary: Beta(2)-adrenergic receptor agonists can stimulate glucose uptake by skeletal muscle cells and are therefore potential treatments for type 2 diabetes. The chirality of compounds has a significant impact on the activity of these agonists. This study found that certain synthesized compounds showed higher glucose uptake activity. These findings provide important information for the design of novel beta(2)AR agonists for T2D treatment.

BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2024)

Article Chemistry, Medicinal

Conformationally constrained potent inhibitors for enhancer of zeste homolog 2 (EZH2)

Xin Xu, Jia Chen, Guan Wang, Xiaojuan Zhang, Qiang Li, Xiaobo Zhou, Fengying Guo, Min Li

Summary: The study focuses on EZH2, a promising therapeutic target for various types of cancers. Researchers designed and synthesized a series of novel derivatives aiming to enhance the EZH2 inhibition activity. Among them, compound 28 displayed potent EZH2 inhibition activity and showed high anti-proliferative effects in lymphoma cell lines and xenograft mouse models. The study suggests that compound 28 has potential as a therapeutic candidate for EZH2-associated cancers.

BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2024)

Article Chemistry, Medicinal

The potential of Rhein's aromatic amines for Parkinson's disease prevention and treatment: α-Synuclein aggregation inhibition and disaggregation of preformed fibers

Wei Zhang, Wei Liu, Ya-Dong Zhao, Li-Zi Xing, Ji Xu, Rui-Jun Li, Yun-Xiao Zhang

Summary: This study developed a series of aromatic amide derivatives based on Rhein and investigated their inhibitory activity against alpha-Syn aggregation. Two of these compounds showed promising potential in treating Parkinson's disease by stabilizing alpha-Syn's conformation and disassembling alpha-Syn oligomers and fibrils.

BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2024)

Article Chemistry, Medicinal

Design, synthesis and biological evaluation of novel cationic liposomes loaded with melphalan for the treatment of cancer

Mani Sharma, S. S. S. S. Sudha Ambadipudi, Neeraj Kumar Chouhan, V. Lakshma Nayak, Srihari Pabbaraja, Sai Balaji Andugulapati, Ramakrishna Sistla

Summary: Therapeutically active lipids in drug delivery systems can enhance the safety and efficacy of treatment. The liposome formulation created using synthesized biologically active lipids showed additive anti-cancer effects and reduced tumorigenic potential.

BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2024)